Please use this identifier to cite or link to this item:
|Title:||Accruals Management, Investor Sophistication, and Equity Valuation: Evidence from 10-Q Filings|
|Series/Report no.:||Eli Bartov-05|
|Appears in Collections:||Accounting Working Papers|
Items in FDA are protected by copyright, with all rights reserved, unless otherwise indicated.